Josephs Paul 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Jul 10, 2025
Insider Transaction Report
Form 4
Josephs Paul
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-08+150,000→ 688,185 total - Exercise/Conversion
Performance-Based Restricted Stock Units
2025-07-08−150,000→ 1,350,000 totalExp: 2029-05-20→ Common Stock (150,000 underlying) - Tax Payment
Common Stock
2025-07-08$8.19/sh−54,857$449,279→ 633,328 total
Footnotes (3)
- [F1]The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone.
- [F2]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the Issuer's common stock achieving certain stock prices.
- [F3]Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the performance stock unit award as reported in Table I.